Liu-Shen-Wan inhibits PI3K/Akt and TRPV1 signaling alleviating bone cancer pain in rats
Patients with advanced-stage cancers often suffer from severe pain caused by bone metastasis and destruction, for which effective treatment options are limited. Liu-Shen-Wan (LSW) is a widely recognized herbal formula utilized for pain relief. This study aims to elucidate the effects of LSW on bone...
Saved in:
| Main Authors: | Hui Zhang, Jingwen Jiang, Xuewu Chen, Fengting Zhu, Fangfang Fu, Aiying Chen, Lei Fu, Dan Mao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2024.2432098 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The depletion of gut microbiome impairs the beneficial effect of Gui-Shen-Wan in restoring mice ovarian function and associated protein expression of ovarian tissues
by: Xingtao Huang, et al.
Published: (2024-11-01) -
Zi Shen Wan Fang repaired blood–brain barrier integrity in diabetic cognitive impairment mice via preventing cerebrovascular cells senescence
by: Qingsheng Yin, et al.
Published: (2024-12-01) -
Estrogen-mediated TRPV5 modulates proliferation and apoptosis of rat cochlear hair cells via the PI3K/Akt pathway
by: Yao Zhou, et al.
Published: (2025-11-01) -
Efficacy and safety of Chinese botanical drug Si Shen Wan in irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials
by: Qian Liu, et al.
Published: (2025-06-01) -
Effect of Liu Wei Di Huang Wan on RAGE,MCP-1 and Fractalkine in blood and urine of patients with lupus nephritis
by: ZHANG Ya-nan
Published: (2017-01-01)